Literature DB >> 26235479

Relationship between cannabis and psychosis: Reasons for use and associated clinical variables.

Anna Mané1, Miguel Fernández-Expósito2, Daniel Bergé3, Laura Gómez-Pérez4, Agnés Sabaté4, Alba Toll4, Laura Diaz4, Cristobal Diez-Aja4, Victor Perez3.   

Abstract

The mechanism underneath the relationship between cannabis and psychosis remains controversial, for which several hypotheses have been proposed, including cannabis as self-medication and cannabis as a risk for the development of psychosis. The aim of this work was to study the relationship between cannabis and psychosis in first-episode psychosis cannabis users and non-users, and non-psychotic cannabis users. The age at the first psychotic episode, duration of untreated psychosis, psychopathology and reasons for cannabis use were assessed. First-episode psychosis cannabis users showed an earlier age at psychosis onset than non-user patients. No significant differences in symptomatology were found. The distinguishing reasons to use cannabis for patients with first-episode psychosis with respect to non-psychotic users were to arrange their thoughts and deal with hallucinations and suspiciousness. These findings are in agreement with both hypotheses: self-medication and secondary psychosis hypothesis. However, longitudinal prospective cohort studies assessing reasons for cannabis use are needed to investigate both hypotheses and their complementarity.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cannabis; First-episode; Reasons for use; Schizophrenia; Self-medication

Mesh:

Year:  2015        PMID: 26235479     DOI: 10.1016/j.psychres.2015.07.070

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  10 in total

Review 1.  Cannabis and development of dual diagnoses: A literature review.

Authors:  Rebecca C Hanna; Jessica M Perez; Subroto Ghose
Journal:  Am J Drug Alcohol Abuse       Date:  2016-09-09       Impact factor: 3.829

2.  Prevalence and clinical correlates of substance use disorders in South African Xhosa patients with schizophrenia.

Authors:  Henk Temmingh; Ezra Susser; Sumaya Mall; Megan Campbell; Goodman Sibeko; Dan J Stein
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2020-08-14       Impact factor: 4.328

3.  Cannabis acute use impacts symptoms and functionality in a cohort of antipsychotic naïve First Episode of Psychosis individuals.

Authors:  Luccas S Coutinho; Hianna Honorato; Cinthia H Higuchi; Daniel A Cavalcante; Sintia Belangeiro; Mariane Noto; Rodrigo A Bressan; Quirino Cordeiro; Cristiano Noto; Ary Gadelha
Journal:  Schizophr Res Cogn       Date:  2018-12-11

4.  A clinical comparison of schizophrenia with and without pre-onset cannabis use disorder: a retrospective cohort study using categorical and dimensional approaches.

Authors:  Samuel Sarrazin; Florence Louppe; Raphael Doukhan; Franck Schürhoff
Journal:  Ann Gen Psychiatry       Date:  2015-12-10       Impact factor: 3.455

5.  The interaction between cannabis use and the Val158Met polymorphism of the COMT gene in psychosis: A transdiagnostic meta - analysis.

Authors:  Thomas Stephanus Johannes Vaessen; Lea de Jong; Annika Theresia Schäfer; Thomas Damen; Aniek Uittenboogaard; Pauline Krolinski; Chinyere Vicky Nwosu; Florentina Maria Egidius Pinckaers; Iris Leah Marije Rotee; Antonius Petrus Wilhelmus Smeets; Ayşegül Ermiş; James L Kennedy; Dorien H Nieman; Arun Tiwari; Jim van Os; Marjan Drukker
Journal:  PLoS One       Date:  2018-02-14       Impact factor: 3.240

6.  Cannabinoids and their therapeutic applications in mental disorders
.

Authors:  Maria Scherma; Anna Lisa Muntoni; Gernot Riedel; Walter Fratta; Paola Fadda
Journal:  Dialogues Clin Neurosci       Date:  2020-09       Impact factor: 5.986

Review 7.  Gut Microbiota and Bipolar Disorder: An Overview on a Novel Biomarker for Diagnosis and Treatment.

Authors:  Lorenza Lucidi; Mauro Pettorruso; Federica Vellante; Francesco Di Carlo; Franca Ceci; Maria Chiara Santovito; Ilenia Di Muzio; Michele Fornaro; Antonio Ventriglio; Carmine Tomasetti; Alessandro Valchera; Alessandro Gentile; Yong-Ku Kim; Giovanni Martinotti; Silvia Fraticelli; Massimo Di Giannantonio; Domenico De Berardis
Journal:  Int J Mol Sci       Date:  2021-04-02       Impact factor: 5.923

8.  Duration of Untreated Disorder and Cannabis Use: An Observational Study on a Cohort of Young Italian Patients Experiencing Psychotic Experiences and Dissociative Symptoms.

Authors:  Valerio Ricci; Giovanni Martinotti; Franca Ceci; Stefania Chiappini; Francesco Di Carlo; Julius Burkauskas; Ottavia Susini; Debora Luciani; Diego Quattrone; Domenico De Berardis; Mauro Pettorruso; Giuseppe Maina; Massimo Di Giannantonio
Journal:  Int J Environ Res Public Health       Date:  2021-11-30       Impact factor: 3.390

9.  Association Between Hormonal Birth Control, Substance Use, and Depression.

Authors:  Sharlene D Newman
Journal:  Front Psychiatry       Date:  2022-02-08       Impact factor: 4.157

Review 10.  [Differential diagnostic distinction between substance-induced and primary psychoses: : Recommendations for general psychiatric and forensic practice].

Authors:  Dusan Hirjak; Andreas Meyer-Lindenberg; Geva A Brandt; Harald Dreßing
Journal:  Nervenarzt       Date:  2021-03-03       Impact factor: 1.214

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.